Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids

Nature Communications

Volumn 10, Issue 1, 2019, Pages

  Miyamoto, Junki ^a,b   Igarashi, Miki ^a   Watanabe, Keita ^a   Karaki, Shin ichiro ^c   Mukouyama, Hiromi ^a   Kishino, Shigenobu ^d   Li, Xuan ^a   Ichimura, Atsuhiko ^d,e   Irie, Junichiro ^b,f   Sugimoto, Yukihiko ^b,g   Mizutani, Tetsuya ^a   Sugawara, Tatsuya ^d   Miki, Takashi ^h   Ogawa, Jun ^d   Drucker, Daniel J ⁱ   Arita, Makoto ^f,j   Itoh, Hiroshi ^b,f   Kimura, Ikuo ^a,b  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e Keihanshin Consortium for Fostering the Next Generation of Global Leaders in Research   (Japan)

^f KEIO UNIVERSITY   (Japan)

^g KUMAMOTO UNIVERSITY   (Japan)

^h CHIBA UNIVERSITY   (Japan)

ⁱ MOUNT SINAI HOSPITAL   (Canada)

^j Institute of Physical and Chemical Research   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E2; RICINOLEIC ACID; TUMOR NECROSIS FACTOR; 10-HYDROXY-CIS-12-OCTADECENOIC ACID; EDIBLE OIL; LINOLEIC ACID; OLEIC ACID; UNSATURATED FATTY ACID;

BIOENERGETICS; FATTY ACID; IMMUNE RESPONSE; METABOLISM; MICROBIAL COMMUNITY; OBESITY; PHYSIOLOGICAL RESPONSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; ENERGY METABOLISM; FAT INTAKE; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC VARIABILITY; GLUCOSE TOLERANCE TEST; HISTOLOGY; HOST RESISTANCE; INSULIN TOLERANCE TEST; INTESTINE FLORA; INTESTINE MOTILITY; LACTOBACILLUS; LIPID ANALYSIS; LIPID DIET; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MASS FRAGMENTOGRAPHY; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SEQUENCE ANALYSIS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WESTERN DIET; ADIPOSE TISSUE; ADVERSE EVENT; ANIMAL; C57BL MOUSE; CELL LINE; DIETARY SUPPLEMENT; DRUG EFFECT; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

LACTOBACILLUS; MUS;

ADIPOSE TISSUE; ANIMALS; CELL LINE; DIET, HIGH-FAT; DIET, WESTERN; DIETARY FATS, UNSATURATED; DIETARY SUPPLEMENTS; ENERGY METABOLISM; FATTY ACIDS, OMEGA-6; FATTY ACIDS, UNSATURATED; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATION; LACTOBACILLUS; LINOLEIC ACID; METABOLIC DISEASES; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; OBESITY; OLEIC ACIDS;

EID: 85071762031     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-019-11978-0     Document Type: Article

References (40)

1. Kahn, S. E., Hull, R. L. & Utzschneider, K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840–846 (2006).
2. Turnbaugh, P. J. et al. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213–223 (2008).
3. Ley, R. E. et al. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022–1023 (2006).
4. Turnbaugh, P. J., Bäckhed, F., Fulton, L. & Gordon, J. I. A core gut microbiome in obese and lean twins. Nature 457, 480–484 (2009).
5. Dalby, M. J., Ross, A. W., Walker, A. W. & Morgan, P. J. Dietary uncoupling of gut microbiota and energy harvesting from obesity and glucose tolerance in mice. Cell Rep. 21, 1521–1533 (2017).
6. Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031 (2006).
7. German, J. B. Saturated fats: what dietary intake? Am. J. Clin. Nutr. 80, 550–559 (2004).
8. Galgani, J. E., Uauy, R. D., Aguirre, C. A. & Díaz, E. O. Effect of the dietary fat quality on insulin sensitivity. Br. J. Nutr. 100, 471–479 (2008).
9. Simopoulos, A. P. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients 8, 128 (2016).
10. Ichimura, A., Hasegawa, S., Kasubuchi, M. & Kimura, I. Free fatty acid receptors as therapeutic targets for the treatment of diabetes. Front. Pharmacol. 5, 236 (2014).
11. Milligan, G., Alvarez-Curto, E., Watterson, K. R., Ulven, T. & Hudson, B. D. Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4. Br. J. Pharmacol. 172, 3254–3265 (2015).
12. Itoh, Y. et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422, 173–176 (2003).
13. Ichimura, A. et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483, 350–354 (2012).
14. Oh, D. Y. et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687–698 (2010).
15. Iakoubov, R., Izzo, A., Yeung, A., Whiteside, C. I. & Brubaker, P. L. Protein kinase Czeta is required for oleic acid-induced secretion of glucagon-like peptide-1 by intestinal endocrine L cells. Endocrinology 148, 1089–1098 (2007).
16. Polan, C. E., Mcneill, J. J. & Tove, S. B. Biohydrogenation of unsaturated fatty acids by rumen bacteria. J. Bacteriol. 88, 1056–1064 (1964).
17. Kishino, S. et al. Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition. Proc. Natl Acad. Sci. USA 110, 17808–17813 (2013).
18. Kishino, S., Ogawa, J., Yokozeki, K. & Shimizu, S. Metabolic diversity in biohydrogenation of polyunsaturated fatty acids by lactic acid bacteria involving conjugated fatty acid production. Appl Microbiol Biotechnol. 84, 87–97 (2009).
19. Kishino, S. et al. Novel multi-component enzyme machinery in lactic acid bacteria catalyzing C=C double bond migration useful for conjugated fatty acid synthesis. Biochem Biophys. Res. Commun. 416, 188–193 (2011).
20. Takeuchi, M. et al. Characterization of the linoleic acid Δ9 hydratase catalyzing the first step of polyunsaturated fatty acid saturation metabolism in Lactobacillus plantarum AKU 1009a. J. Biosci. Bioeng. 119, 636–641 (2015).
21. Miyamoto, J. et al. A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR40-MEK-ERK pathway. J. Biol. Chem. 290, 2902–2918 (2015).
22. Nanthirudjanar, T. et al. Gut microbial fatty acid metabolites reduce triacylglycerol levels in hepatocytes. Lipids 50, 1093–1102 (2015).
23. Ohue-Kitano, R. et al. α-Linolenic acid-derived metabolites from gut lactic acid bacteria induce differentiation of anti-inflammatory M2 macrophages through G protein-coupled receptor 40. FASEB J. 32, 304–318 (2018).
24. Kaikiri, H. et al. Supplemental feeding of a gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, alleviates spontaneous atopic dermatitis and modulates intestinal microbiota in NC/nga mice. Int J. Food Sci. Nutr. 68, 941–951 (2017).
25. Buckley, C. D., Gilroy, D. W. & Serhan, C. N. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity 40, 315–327 (2014).
26. Greiner, T. U. & Bäckhed, F. Microbial regulation of GLP-1 and L-cell biology. Mol. Metab. 5, 753–758 (2016).
27. Hara, T. et al. Novel selective ligands for free fatty acid receptors GPR120 and GPR40. Naunyn Schmiede. Arch. Pharmacol. 380, 247–255 (2009).
28. Winzell, M. S. & Ahrén, B. G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacol. Ther. 116, 437–448 (2007).
29. Tunaru, S., Althoff, T. F., Nüsing, R. M., Diener, M. & Offermanns, S. Castor oil induces laxation and uterus contraction via ricinoleic acid activating prostaglandin EP3 receptors. Proc. Natl Acad. Sci. USA 109, 9179–9184 (2012).
30. Im, D. S. Intercellular lipid mediators and GPCR drug discovery. Biomol. Ther. (Seoul.). 21, 411–422 (2013).
31. Arita, M. Mediator lipidomics in acute inflammation and resolution. J. Biochem. 152, 313–319 (2012).
32. Vigsnaes, L. K. et al. Microbiotas from UC patients display altered metabolism and reduced ability of LAB to colonize mucus. Sci. Rep. 3, 1110 (2013).
33. Kimura, I. et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4, 1829 (2013).
34. Nakajima, A. et al. The short chain fatty acid receptor GPR43 regulates inflammatory signals in adipose tissue M2-type macrophages. PLoS ONE 12, e0179696 (2017).
35. Kimura, I. et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc. Natl Acad. Sci. USA 108, 8030–8035 (2011).
36. Miki, T. et al. Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility. Diabetes 54, 1056–1063 (2005).
37. Lee, Y. C. et al. Glucagon gene 5’-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice. J. Biol. Chem. 267, 10705–10708 (1992).
38. Hara, T. et al. Flow cytometry-based binding assay for GPR40 (FFAR1; free fatty acid receptor 1). Mol. Pharmacol. 75, 85–91 (2009).
39. Hirasawa, A. et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 11, 90–94 (2005).
40. Iizuka, Y., Kuwahara, A. & Karaki, S. Role of PGE2 in the colonic motility: PGE2 generates and enhances spontaneous contractions of longitudinal smooth muscle in the rat colon. J. Physiol. Sci. 64, 85–96 (2014).